当前位置：首页 > 文献互助 > 互助详情

期刊论文A first-in-human phase 1/2 dose-escalation study of MAK683 (EED inhibitor) in patients with advanced malignancies复制

用户7nEFK6amBq5Y 2个月前 91 已完结

1. 系统已在2025-06-12 16:59:48对应助文件进行删除

2. 如有需要请重新发布求助信息

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

其他信息:

互助时间线

楼主确认了jodie0105应助的文件是正确的, 求助状态变成已完结

jodie0105上传了文件(zip 2.56 MB), 求助状态变成待确认

Diagnosis and Management of Acute Venous Thromboembolism in Pregnancy and the Puerperium: A Comprehensive Review of Guidelines 4分钟前

Targeting the IL-15/CD122 signaling pathway: reversing TRM cell-mediated immune memory in vitiligo 15分钟前

Associations Between Clinical Factors and Postoperative Thrombosis in Pediatric Cardiac Surgery Patients 26分钟前

Inadequate Anti-factor Xa Levels with Daily 40 mg Enoxaparin Post Cardiac Surgery 27分钟前

Ink Engineering in Blade-Coating Large-Area Perovskite Solar Cells 50分钟前

决奈达隆临床应用的中国专家建议 1小时前

Biologic Agents in the Treatment of Glomerular Diseases: Current Status and Future 1小时前

Flash floods: why are more of them devastating the world’s driest regions? 12小时前

Harnessing tyrosine kinase 2: Breakthroughs in autoimmune disease and cancer therapy 13小时前